Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Other 3Head & Neck 2Gastrointestinal 2Genitourinary 1Classical hematology 1CNS 1Breast 1

Conditions

Obesity 112Neoplasms 43Sexual Dysfunction, Physiological 31Polycystic Ovary Syndrome 27Overweight 18Breast Neoplasms 18Diabetes Mellitus 16Colorectal Neoplasms 16Dyspnea 14Diabetes Mellitus, Type 2 13Obesity, Morbid 12Mucositis 12Constipation 12Depression 11Prostatic Neoplasms 10Lung Neoplasms 10Hypertension 10Pulmonary Disease, Chronic Obstructive 9Non-alcoholic Fatty Liver Disease 9Metabolic Syndrome 9Insulin Resistance 9Motor Activity 8Cardiovascular Diseases 8Renal Insufficiency, Chronic 7Opioid-Induced Constipation 7Heart Failure 7Asthma 7Sarcopenia 6Rectal Neoplasms 6Multiple Myeloma 6

Interventions

semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Qsymia 1Phentermine 1Naltrexone 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Electrocardiography 1Diethylpropion 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Dyslipidemias × Other × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

NCT04442334 2023-01-06

The European NAFLD Registry

Newcastle University

Recruiting
10,000 enrolled
GastrointestinalOther

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Hypertension, Liver Cirrhosis, Obesity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡